| T-BSDB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Tandem Diabody) |
Human |
|
C. albicans |
CD64 |
Inquiry |
| SCIGG-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
C. albicans |
CD64 |
Inquiry |
| FVTIG-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
C. albicans |
CD64 |
Inquiry |
| BSSG-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
C. albicans |
CD64 |
Inquiry |
| IGLFV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
C. albicans |
CD64 |
Inquiry |
| BSGV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
C. albicans |
CD64 |
Inquiry |
| BSDG-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
C. albicans |
CD64 |
Inquiry |
| BABFV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
C. albicans |
CD64 |
Inquiry |
| FABVC-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
C. albicans |
CD64 |
Inquiry |
| SCDBC-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
C. albicans |
CD64 |
Inquiry |
| BSDBC-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
C. albicans |
CD64 |
Inquiry |
| SCDBF-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
C. albicans |
CD64 |
Inquiry |
| BSFVF-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
C. albicans |
CD64 |
Inquiry |
| BSDBF-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
C. albicans |
CD64 |
Inquiry |
| BSTF-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-Fc-scFv |
C. albicans |
CD64 |
Inquiry |
| BSCFV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scFv-Fc) |
Human |
scFv-Fc |
C. albicans |
CD64 |
Inquiry |
| MNAB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Miniantibody) |
Human |
Miniantibody |
C. albicans |
CD64 |
Inquiry |
| BSFC-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scFv-CH3) |
Human |
scFv-CH3 |
C. albicans |
CD64 |
Inquiry |
| BSCC-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-CH1/CL |
C. albicans |
CD64 |
Inquiry |
| BIBD-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Bibody) |
Human |
Bibody |
C. albicans |
CD64 |
Inquiry |
| FABFV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
C. albicans |
CD64 |
Inquiry |
| MiniB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Minibody) |
Human |
Minibody |
C. albicans |
CD64 |
Inquiry |
| SCTB-005 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
C. albicans |
CD64 |
Inquiry |
| SCDB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
C. albicans |
CD64 |
Inquiry |
| FABIG-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
C. albicans |
CD64 |
Inquiry |
| TRIB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
C. albicans |
CD64 |
Inquiry |
| BSIG-023 |
Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
C. albicans |
CD64 |
Inquiry |
| CROSSAB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
C. albicans |
CD64 |
Inquiry |
| IGFV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
C. albicans |
CD64 |
Inquiry |
| BSDB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
C. albicans |
CD64 |
Inquiry |
| BSFAB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
C. albicans |
CD64 |
Inquiry |
| BSFV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
C. albicans |
CD64 |
Inquiry |
| FABIG-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
GD2 |
Inquiry |
| FABIG-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
EGFR |
Inquiry |
| FABIG-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD37 |
CD64 |
Inquiry |
| FABIG-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD33 |
CD64 |
Inquiry |
| FABIG-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD30 |
CD64 |
Inquiry |
| FABIG-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD19 |
CD64 |
Inquiry |
| FABIG-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD15 |
CD64 |
Inquiry |
| FABIG-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Fab-IgG) |
Mouse |
Fab-IgG |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| TRIB-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
DENV |
CD64 |
Inquiry |
| TRIB-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
Malaria Antigen |
Inquiry |
| TRIB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
HER2 |
Inquiry |
| TRIB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
HIV-1 gp41 |
Inquiry |
| TRIB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
GD2 |
Inquiry |
| TRIB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
EGFR |
Inquiry |
| TRIB-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD37 |
CD64 |
Inquiry |
| TRIB-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD33 |
CD64 |
Inquiry |
| TRIB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD30 |
CD64 |
Inquiry |
| TRIB-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD19 |
CD64 |
Inquiry |
| TRIB-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD15 |
CD64 |
Inquiry |
| TRIB-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Triple Body) |
Mouse |
Triple Body |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| BSIG-147 |
Anti-DENV x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
DENV |
CD64 |
Inquiry |
| BSIG-129 |
Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
Malaria Antigen |
Inquiry |
| BSIG-128 |
Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
HER2 |
Inquiry |
| BSIG-127 |
Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
HIV-1 gp41 |
Inquiry |
| BSIG-126 |
Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
GD2 |
Inquiry |
| BSIG-125 |
Anti-CD64 x Anti-EGFR Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
EGFR |
Inquiry |
| BSIG-117 |
Anti-CD37 x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD37 |
CD64 |
Inquiry |
| BSIG-115 |
Anti-CD33 x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD33 |
CD64 |
Inquiry |
| BSIG-110 |
Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD30 |
CD64 |
Inquiry |
| BSIG-044 |
Anti-CD19 x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD19 |
CD64 |
Inquiry |
| BSIG-032 |
Anti-CD15 x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD15 |
CD64 |
Inquiry |
| BSIG-001 |
Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Mouse |
IgG-IgG |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| CROSSAB-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
DENV |
CD64 |
Inquiry |
| CROSSAB-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
Malaria Antigen |
Inquiry |
| CROSSAB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
HER2 |
Inquiry |
| CROSSAB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
HIV-1 gp41 |
Inquiry |
| CROSSAB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
GD2 |
Inquiry |
| CROSSAB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
EGFR |
Inquiry |
| CROSSAB-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD37 |
CD64 |
Inquiry |
| CROSSAB-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD33 |
CD64 |
Inquiry |
| CROSSAB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD30 |
CD64 |
Inquiry |
| CROSSAB-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD19 |
CD64 |
Inquiry |
| CROSSAB-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD15 |
CD64 |
Inquiry |
| CROSSAB-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (CrossMab) |
Mouse |
CrossMab |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| IGFV-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
DENV |
CD64 |
Inquiry |
| IGFV-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
Malaria Antigen |
Inquiry |
| IGFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
HER2 |
Inquiry |
| IGFV-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
HIV-1 gp41 |
Inquiry |
| IGFV-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
GD2 |
Inquiry |
| IGFV-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
EGFR |
Inquiry |
| IGFV-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD37 |
CD64 |
Inquiry |
| IGFV-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD33 |
CD64 |
Inquiry |
| IGFV-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD30 |
CD64 |
Inquiry |
| IGFV-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD19 |
CD64 |
Inquiry |
| IGFV-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD15 |
CD64 |
Inquiry |
| IGFV-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Mouse |
IgG-scFv |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| BSDB-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
DENV |
CD64 |
Inquiry |
| BSDB-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
Malaria Antigen |
Inquiry |
| BSDB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
HER2 |
Inquiry |
| BSDB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
HIV-1 gp41 |
Inquiry |
| BSDB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
GD2 |
Inquiry |
| BSDB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
EGFR |
Inquiry |
| BSDB-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD37 |
CD64 |
Inquiry |
| BSDB-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD33 |
CD64 |
Inquiry |
| BSDB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD30 |
CD64 |
Inquiry |
| BSDB-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD19 |
CD64 |
Inquiry |
| BSDB-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD15 |
CD64 |
Inquiry |
| BSDB-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Diabody) |
Mouse |
Diabody |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| BSFAB-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
DENV |
CD64 |
Inquiry |
| BSFAB-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
Malaria Antigen |
Inquiry |
| BSFAB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
HER2 |
Inquiry |
| BSFAB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
HIV-1 gp41 |
Inquiry |
| BSFAB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
GD2 |
Inquiry |
| BSFAB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
EGFR |
Inquiry |
| BSFAB-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD37 |
CD64 |
Inquiry |
| BSFAB-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD33 |
CD64 |
Inquiry |
| BSFAB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD30 |
CD64 |
Inquiry |
| BSFAB-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD19 |
CD64 |
Inquiry |
| BSFAB-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD15 |
CD64 |
Inquiry |
| BSFAB-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Mouse |
Tandem Fab |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| BSFV-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
DENV |
CD64 |
Inquiry |
| BSFV-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
Malaria Antigen |
Inquiry |
| BSFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
HER2 |
Inquiry |
| BSFV-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
HIV-1 gp41 |
Inquiry |
| BSFV-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
GD2 |
Inquiry |
| BSFV-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
EGFR |
Inquiry |
| BSFV-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD37 |
CD64 |
Inquiry |
| BSFV-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD33 |
CD64 |
Inquiry |
| BSFV-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD30 |
CD64 |
Inquiry |
| BSFV-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD19 |
CD64 |
Inquiry |
| BSFV-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD15 |
CD64 |
Inquiry |
| BSFV-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Mouse |
Tandem scFv |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
Fig.1 Schematic diagram of phagocytes orchestrating sterilizing immunity in systemic fungal infection.1
